Reassessment of Neuroprotective Efficacy of TUDCA in Ischemic Stroke: A Multi-Model In Vivo and In Vitro Study
Ischemic stroke accounts for 87% of all strokes and remains a leading cause of mortality and morbidity worldwide, yet therapeutic options remain limited. Emerging evidence on the gut-brain axis and microbial metabolites as modulators of stroke outcome has positioned tauroursodeoxycholic acid (TUDCA), a taurine-conjugat...